Jump to:Page Content
Semester: Spr Mod3
Faculty: Suerie Moon
|Meet Day||F||10:00 AM - 12:50 PM||HSPH FXB G10|
Public health challenges - for example, pandemic flu, HIV/AIDS, obesity, neglected diseases, or tobacco use - increasingly shape and are shaped by the political, economic, and social aspects of globalization. Outbreaks of new infectious diseases, such as SARS or H1N1 flu, can wreak immediate economic havoc on a regional or global scale. Neglected diseases, such as sleeping sickness, continue to cause immense human suffering. Meanwhile, international rules that fall outside the traditional health sphere - such as those governing intellectual property, trade in agriculture, human migration, and greenhouse gas emissions - can have profound impacts on human health. While strong national health systems are critical for meeting the needs of their populations, the effects of and capacities to respond to a particular health threat often lie outside the control of any one nation state. How suitable are existing international/global and national institutions for responding effectively and equitably to such challenges? What functions must the 'global health system' achieve? Where are the major governance gaps? What institutional innovations have succeeded? And how can we improve our collective capacity to respond to the increasingly complex nature of global health challenges? Through an intensive half-semester module, this course is intended to equip students with an analytic approach to answering these questions through: a basic introduction to major public health challenges and key questions in global governance; an understanding of the current functioning of the global health system and its shortcomings; and exposure to new approaches to addressing global public health challenges. The course will include case studies of innovative governance arrangements such as: the Framework Convention on Tobacco Control; the revised International Health Regulations; the Global Fund to Fight AIDS, Tuberculosis and Malaria; and product development partnerships for drug development, among others. The course is expected to be of particular interest to students of public health and public policy, but is open to all graduate students across the University.
Also offered by the School of Public Health as GHP 548.